{"id":24424,"date":"2021-03-18T10:31:17","date_gmt":"2021-03-18T09:31:17","guid":{"rendered":"https:\/\/www.aipd.it\/site\/?p=24424"},"modified":"2021-04-19T15:49:10","modified_gmt":"2021-04-19T13:49:10","slug":"icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down","status":"publish","type":"post","link":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/","title":{"rendered":"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1216.8px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-text fusion-text-1\"><p>Il <a href=\"https:\/\/cordis.europa.eu\/project\/id\/899986\"><strong>Progetto ICOD<\/strong> (H2020-EU.3.1.3.)<\/a> \u00e8 stato finanziato nell\u2019ambito della call \u201cEuropean Commission New interventions for Non-Communicable Diseases call of the H2020 Programme\u201d First Stage application to SC1-BHC-08-2020. Il principale obiettivo \u00e8 dimostrare l\u2019efficacia clinica dell\u2019AEF0217 nel trattamento dei deficit cognitivi nella Sindrome di Down attraverso uno studio di fase I e uno studio clinico multicentrico randomizzato controllato di fase II. L\u2019approccio innovativo del progetto deriva anche dall\u2019utilizzo di una nuova strategia di valutazione psicometrica, in cui saranno utilizzati nell\u2019uomo gli stessi strumenti psicometrici adottati a livello preclinico. <a href=\"https:\/\/www.aipd.it\/site\/wp-content\/uploads\/2021\/03\/ICOD-Comunicato_ProgettoEuropeo_ICOD_ITA_21Marzo.pdf\"><strong>QUI il comunicato stampa ufficiale<\/strong><\/a>.<\/p>\n<p>Il consorzio Europeo dell\u2019H2020 EU-funded ICOD project (Grant agreement n\u00b0 899986) \u00e8 guidato dal Prof. Rafael De la Torre dell\u2019<a href=\"https:\/\/www.imim.cat\/en_index.html\">IMIM<\/a> (Barcelona, Spagna) e da <a href=\"https:\/\/www.aelisfarma.com\/\">AELIS FARMA<\/a> (Pier Vincenzo Piazza, Bordeaux, Francia) in collaborazione con l\u2019<a href=\"http:\/\/www.irccs.oasi.en.it\/\">IRCCS Oasi di Troina<\/a> dove il coordinatore per le attivit\u00e0 di dissemination a livello europeo sar\u00e0 il Prof. Filippo Caraci, Docente di Farmacologia presso il DSFS di UniCT e Responsabile dell\u2019UOR di Neurofarmacologia presso l\u2019Oasi di Troina. Altri partner del progetto sono l\u2019<a href=\"https:\/\/www.institutlejeune.org\/\">Institut J\u00e9r\u00f4me Lejeune<\/a> (Sophie Durand, Parigi, Francia), il <a href=\"https:\/\/www.hospitalby.it\/ospedale-costa-davorio\/centre-hospitalier-universitaire.by\/\">Centre Hospitalier Universitaire di Saint-Etienne<\/a> (Francia) con il Prof. Renaud Touraine e l\u2019<a href=\"https:\/\/www.comunidad.madrid\/centros\/hospital-universitario-princesa\">Hospital Universitario de la Princesa<\/a> (Dr. Diego Real de As\u00faa, SERMAS, Madrid, Spagna).<br \/>\nL\u2019obiettivo finale del <strong>progetto ICOD<\/strong> \u00e8 rendere disponibile il primo farmaco per la SD dopo 7 anni di sviluppo clinico, offrendo alle persone con SD ed alle loro famiglie un nuovo approccio farmacologico per il trattamento dei deficit cognitivi nella SD.<\/p>\n<p>AIPD ha espresso il suo sostegno all&#8217;iniziativa e la &#8220;<em>disponibilit\u00e0 ad esaminare, con il supporto del consiglio scientifico, il protocollo che questo progetto generer\u00e0 per disegnare nuove strade terapeutiche per migliorare la funzione cerebrale nelle disabilit\u00e0 cognitive. Il coinvolgimento dell&#8217;AIPD sar\u00e0 subordinato alla definizione di un investigatore italiano partecipante allo studio e all&#8217;approvazione di un comitato etico italiano<\/em>&#8220;.<\/p>\n<\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:100% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 1.92%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 1.92%;}@media only screen and (max-width:1024px) {.fusion-body .fusion-builder-column-0{width:100% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;order : 0;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":24425,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84,449],"tags":[432],"wf_post_folders":[],"class_list":["post-24424","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","category-salute","tag-ricerca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down - AIPD Sede Nazionale<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down - AIPD Sede Nazionale\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/\" \/>\n<meta property=\"og:site_name\" content=\"AIPD Sede Nazionale\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Associazione-Italiana-Persone-Down-ONLUS\/91463979840?fref=ts\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-18T09:31:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-04-19T13:49:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.aipd.it\/site\/wp-content\/uploads\/2021\/03\/european-commission-canva2000x1000.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Patrizia Danesi\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AIPDnazionale\" \/>\n<meta name=\"twitter:site\" content=\"@AIPDnazionale\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patrizia Danesi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/\"},\"author\":{\"name\":\"Patrizia Danesi\",\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/#\\\/schema\\\/person\\\/d103d584e1ebc8f6de34c2139bcb4a77\"},\"headline\":\"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down\",\"datePublished\":\"2021-03-18T09:31:17+00:00\",\"dateModified\":\"2021-04-19T13:49:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/\"},\"wordCount\":921,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/european-commission-canva2000x1000.jpg\",\"keywords\":[\"ricerca\"],\"articleSection\":[\"Notizie\",\"Salute\"],\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/\",\"url\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/\",\"name\":\"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down - AIPD Sede Nazionale\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/european-commission-canva2000x1000.jpg\",\"datePublished\":\"2021-03-18T09:31:17+00:00\",\"dateModified\":\"2021-04-19T13:49:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/european-commission-canva2000x1000.jpg\",\"contentUrl\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/european-commission-canva2000x1000.jpg\",\"width\":2000,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/\",\"name\":\"AIPD Sede Nazionale\",\"description\":\"Associazione Italiana Persone Down\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/#organization\",\"name\":\"Associazione Italiana Persone Down\",\"url\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/logo-140x140-sito.png\",\"contentUrl\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/wp-content\\\/uploads\\\/2019\\\/02\\\/logo-140x140-sito.png\",\"width\":140,\"height\":140,\"caption\":\"Associazione Italiana Persone Down\"},\"image\":{\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/pages\\\/Associazione-Italiana-Persone-Down-ONLUS\\\/91463979840?fref=ts\",\"https:\\\/\\\/x.com\\\/AIPDnazionale\",\"https:\\\/\\\/www.instagram.com\\\/aipd_nazionale\\\/\",\"http:\\\/\\\/www.youtube.com\\\/user\\\/NazionaleAIPD\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/#\\\/schema\\\/person\\\/d103d584e1ebc8f6de34c2139bcb4a77\",\"name\":\"Patrizia Danesi\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f7d35e574294a0ecbd0e0330d28d485e1a59b0e2b618165c78d79bc78928308c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f7d35e574294a0ecbd0e0330d28d485e1a59b0e2b618165c78d79bc78928308c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f7d35e574294a0ecbd0e0330d28d485e1a59b0e2b618165c78d79bc78928308c?s=96&d=mm&r=g\",\"caption\":\"Patrizia Danesi\"},\"url\":\"https:\\\/\\\/www.aipd.it\\\/site\\\/author\\\/patrizia-danesi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down - AIPD Sede Nazionale","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/","og_locale":"it_IT","og_type":"article","og_title":"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down - AIPD Sede Nazionale","og_url":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/","og_site_name":"AIPD Sede Nazionale","article_publisher":"https:\/\/www.facebook.com\/pages\/Associazione-Italiana-Persone-Down-ONLUS\/91463979840?fref=ts","article_published_time":"2021-03-18T09:31:17+00:00","article_modified_time":"2021-04-19T13:49:10+00:00","og_image":[{"width":2000,"height":1000,"url":"https:\/\/www.aipd.it\/site\/wp-content\/uploads\/2021\/03\/european-commission-canva2000x1000.jpg","type":"image\/jpeg"}],"author":"Patrizia Danesi","twitter_card":"summary_large_image","twitter_creator":"@AIPDnazionale","twitter_site":"@AIPDnazionale","twitter_misc":{"Scritto da":"Patrizia Danesi","Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/#article","isPartOf":{"@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/"},"author":{"name":"Patrizia Danesi","@id":"https:\/\/www.aipd.it\/site\/#\/schema\/person\/d103d584e1ebc8f6de34c2139bcb4a77"},"headline":"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down","datePublished":"2021-03-18T09:31:17+00:00","dateModified":"2021-04-19T13:49:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/"},"wordCount":921,"commentCount":0,"publisher":{"@id":"https:\/\/www.aipd.it\/site\/#organization"},"image":{"@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aipd.it\/site\/wp-content\/uploads\/2021\/03\/european-commission-canva2000x1000.jpg","keywords":["ricerca"],"articleSection":["Notizie","Salute"],"inLanguage":"it-IT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/","url":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/","name":"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down - AIPD Sede Nazionale","isPartOf":{"@id":"https:\/\/www.aipd.it\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/#primaryimage"},"image":{"@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/#primaryimage"},"thumbnailUrl":"https:\/\/www.aipd.it\/site\/wp-content\/uploads\/2021\/03\/european-commission-canva2000x1000.jpg","datePublished":"2021-03-18T09:31:17+00:00","dateModified":"2021-04-19T13:49:10+00:00","breadcrumb":{"@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/#primaryimage","url":"https:\/\/www.aipd.it\/site\/wp-content\/uploads\/2021\/03\/european-commission-canva2000x1000.jpg","contentUrl":"https:\/\/www.aipd.it\/site\/wp-content\/uploads\/2021\/03\/european-commission-canva2000x1000.jpg","width":2000,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/www.aipd.it\/site\/icod-al-via-un-progetto-internazionale-per-studiare-un-innovativo-approccio-farmacologico-alla-sindrome-di-down\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.aipd.it\/site\/"},{"@type":"ListItem","position":2,"name":"ICOD, al via un progetto internazionale per studiare un innovativo approccio farmacologico alla Sindrome di Down"}]},{"@type":"WebSite","@id":"https:\/\/www.aipd.it\/site\/#website","url":"https:\/\/www.aipd.it\/site\/","name":"AIPD Sede Nazionale","description":"Associazione Italiana Persone Down","publisher":{"@id":"https:\/\/www.aipd.it\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aipd.it\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.aipd.it\/site\/#organization","name":"Associazione Italiana Persone Down","url":"https:\/\/www.aipd.it\/site\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.aipd.it\/site\/#\/schema\/logo\/image\/","url":"https:\/\/www.aipd.it\/site\/wp-content\/uploads\/2019\/02\/logo-140x140-sito.png","contentUrl":"https:\/\/www.aipd.it\/site\/wp-content\/uploads\/2019\/02\/logo-140x140-sito.png","width":140,"height":140,"caption":"Associazione Italiana Persone Down"},"image":{"@id":"https:\/\/www.aipd.it\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pages\/Associazione-Italiana-Persone-Down-ONLUS\/91463979840?fref=ts","https:\/\/x.com\/AIPDnazionale","https:\/\/www.instagram.com\/aipd_nazionale\/","http:\/\/www.youtube.com\/user\/NazionaleAIPD"]},{"@type":"Person","@id":"https:\/\/www.aipd.it\/site\/#\/schema\/person\/d103d584e1ebc8f6de34c2139bcb4a77","name":"Patrizia Danesi","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/f7d35e574294a0ecbd0e0330d28d485e1a59b0e2b618165c78d79bc78928308c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f7d35e574294a0ecbd0e0330d28d485e1a59b0e2b618165c78d79bc78928308c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f7d35e574294a0ecbd0e0330d28d485e1a59b0e2b618165c78d79bc78928308c?s=96&d=mm&r=g","caption":"Patrizia Danesi"},"url":"https:\/\/www.aipd.it\/site\/author\/patrizia-danesi\/"}]}},"_links":{"self":[{"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/posts\/24424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/comments?post=24424"}],"version-history":[{"count":0,"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/posts\/24424\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/media\/24425"}],"wp:attachment":[{"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/media?parent=24424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/categories?post=24424"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/tags?post=24424"},{"taxonomy":"wf_post_folders","embeddable":true,"href":"https:\/\/www.aipd.it\/site\/wp-json\/wp\/v2\/wf_post_folders?post=24424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}